Effect of endodontic treatment on endothelial dysfunction and subclinical atherosclerosis-a prospective intervention study

被引:1
作者
Chauhan, Nishant [1 ]
Mittal, Shweta [1 ]
Tewari, Sanjay [1 ]
Sen, Jyotsna [2 ]
Laller, Kuldip [2 ]
机构
[1] Post Grad Inst Dent Sci, Rohtak 124001, Haryana, India
[2] Post Grad Inst Med Sci, Rohtak 124001, Haryana, India
关键词
Root canal therapy; Flow-mediated dilatation; Carotid intima-media thickness; Periapical periodontitis; Diagnostic imaging; Cardiovascular disease; INTIMA-MEDIA THICKNESS; CAROTID-ARTERY INTIMA; APICAL PERIODONTITIS; CARDIOVASCULAR RISK; YOUNG-ADULTS; ASSOCIATION; DISEASE; MARKERS; INFECTION; HEALTH;
D O I
10.1007/s00784-023-05183-z
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
ObjectiveThe objective of this study is to investigate the effect of endodontic treatment on flow-mediated dilatation (FMD) and carotid intima-media thickness (c-IMT) in patients with apical periodontitis (AP).Material and methodThe study includes 32 young men having AP with a mean age of 25.78 years free from cardiovascular disease (CVD) and its risk factors, including periodontitis. All subjects underwent complete physical and dental examination, echocardiography, and ultrasound assessment of FMD on the brachial artery and c-IMT on the carotid artery at baseline and 12 months after the endodontic treatment. Data were analyzed using paired Student's t-test and Pearson's correlation coefficient (r) test using SPSS 26 version.ResultsEndodontic treatment leads to the improvement of FMD significantly from a pooled baseline value of 4.84 & PLUSMN; 1.55% to 7.68 & PLUSMN; 2.08% (p < 0.05). The study also depicts a statistically significant difference between c-IMT (mean = 0.62 & PLUSMN; 0.11 mm) before treatment as compared to 12 months after treatment (mean = 0.59 & PLUSMN; 0.11 mm) (p < 0.05).ConclusionEndodontic treatment leads to improved FMD and decreased c-IMT suggesting that treating AP can be help revert the early stages of CVD.
引用
收藏
页码:5617 / 5625
页数:9
相关论文
共 50 条
  • [31] Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis
    D'Abramo, Alessandra
    Zingaropoli, Maria Antonella
    Oliva, Alessandra
    D'Agostino, Claudia
    Al Moghazi, Samir
    De Luca, Giulia
    Iannetta, Marco
    Mastroianni, Claudio Maria
    Vullo, Vincenzo
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [32] Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus
    Parasar Ghosh
    Amresh Kumar
    Sudeep Kumar
    Amita Aggarwal
    Nakul Sinha
    Ramnath Misra
    Clinical Rheumatology, 2009, 28 : 1259 - 1265
  • [33] HIV Is Associated With Subclinical Coronary Atherosclerosis: A Prospective Matched Cohort Study
    Knudsen, Andreas D.
    Fuchs, Andreas
    Benfield, Thomas
    Kober, Lars
    Nordestgaard, Borge Gronne
    Afzal, Shoaib
    Kuhl, Jorgen Tobias
    Sigvardsen, Per Ejlstrup
    Suarez-Zdunek, Moises Alberto
    Gelpi, Marco
    Nielsen, Susanne D.
    Kofoed, Klaus F.
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [34] The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis
    Liu, Shanshan
    Wang, Jialu
    Wu, Shujing
    Niu, Jingya
    Zheng, Ruizhi
    Bie, Lizhan
    Xin, Zhuojun
    Wang, Shuangyuan
    Lin, Hong
    Zhao, Zhiyun
    Wang, Tiange
    Xu, Min
    Lu, Jieli
    Chen, Yuhong
    Xu, Yiping
    Wang, Weiqing
    Ning, Guang
    Bi, Yufang
    Li, Mian
    Xu, Yu
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 120
  • [35] Effect of biologics targeting interleukin-23/-17 axis on subclinical atherosclerosis: results of a pilot study
    Marovt, M.
    Marko, P. B.
    Pirnat, M.
    Ekart, R.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (05) : 560 - 564
  • [36] Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis and Cardiac Dysfunction in Middle Age: The CARDIA Study
    Reis, Jared P.
    Allen, Norrina B.
    Bancks, Michael P.
    Carr, J. Jeffrey
    Lewis, Cora E.
    Lima, Joao A.
    Rana, Jamal S.
    Gidding, Samuel S.
    Schreiner, Pamela J.
    DIABETES CARE, 2018, 41 (04) : 731 - 738
  • [37] Association of endothelial and oxidative stress with metabolic syndrome and subclinical atherosclerosis: multi-ethnic study of atherosclerosis
    Vaidya, D.
    Szklo, M.
    Cushman, M.
    Holvoet, P.
    Polak, J.
    Bahrami, H.
    Jenny, N. S.
    Ouyang, P.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2011, 65 (07) : 818 - 825
  • [38] Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA)
    Feldman, David I.
    Cainzos-Achirica, Miguel
    Billups, Kevin L.
    DeFilippis, Andrew P.
    Chitaley, Kanchan
    Greenland, Philip
    Stein, James H.
    Budoff, Matthew J.
    Dardari, Zeina
    Miner, Martin
    Blumenthal, Roger S.
    Nasir, Khurram
    Blaha, Michael J.
    CLINICAL CARDIOLOGY, 2016, 39 (05) : 291 - 298
  • [39] Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study
    Di Yacovo, Silvana
    Saumoy, Maria
    Luis Sanchez-Quesada, Jose
    Navarro, Antonio
    Sviridov, Dmitri
    Javaloyas, Manuel
    Vila, Ramon
    Vernet, Anton
    Low, Hann
    Penafiel, Judith
    Garcia, Benito
    Ordonez-Llanos, Jordi
    Podzamczer, Daniel
    PLOS ONE, 2020, 15 (08):
  • [40] Life's essential 8 and risk of subclinical atherosclerosis pro- gression: a prospective cohort study
    Zhou, Shi-Yu
    Liu, Fang-Chao
    Chen, Shu-Feng
    Li, Jian-Xin
    Cao, Jie
    Huang, Ke-Yong
    Tang, Zheng-Hao
    Liang, Feng-Chao
    Hu, Dong-Sheng
    Zhao, Lian-Cheng
    Li, Ying
    Huang, Jian-Feng
    Lu, Xiang-Feng
    Lu, Bin
    Gu, Dong-Feng
    JOURNAL OF GERIATRIC CARDIOLOGY, 2024, 21 (07) : 751 - 759